USS Investment Management Ltd Has $8.69 Million Position in Mettler-Toledo International, Inc. $MTD

Key Points

• USS Investment Management Ltd has increased its stake in Mettler-Toledo International, Inc. by 5.6%, owning $8.69 million worth of shares after acquiring an additional 390 shares.
• Mettler-Toledo reported a Q2 EPS of $10.09, exceeding estimates, with a revenue of $983.22 million, reflecting a 3.9% year-over-year growth.
• Analysts have a current consensus rating of "Moderate Buy" for Mettler-Toledo, with an average price target of $1,311.11, indicating potential upside from current market levels.

USS Investment Management Ltd grew its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 5.6% in the first quarter, according to its most recent filing with the SEC. The fund owned 7,350 shares of the medical instruments supplier's stock after acquiring an additional 390 shares during the period. USS Investment Management Ltd's holdings in Mettler-Toledo International were worth $8,686,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of MTD. GAMMA Investing LLC lifted its position in shares of Mettler-Toledo International by 131,246.3% during the 1st quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock valued at $456,018,000 after acquiring an additional 385,864 shares during the last quarter. Alliancebernstein L.P. lifted its holdings in shares of Mettler-Toledo International by 21.6% in the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock valued at $837,653,000 after purchasing an additional 126,147 shares in the last quarter. Nuveen LLC purchased a new stake in shares of Mettler-Toledo International in the first quarter valued at $71,897,000. AustralianSuper Pty Ltd lifted its holdings in shares of Mettler-Toledo International by 60.4% in the first quarter. AustralianSuper Pty Ltd now owns 114,986 shares of the medical instruments supplier's stock valued at $135,788,000 after purchasing an additional 43,313 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. lifted its holdings in shares of Mettler-Toledo International by 11.9% in the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier's stock valued at $479,673,000 after purchasing an additional 43,082 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on MTD shares. UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their target price for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Barclays started coverage on Mettler-Toledo International in a report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 target price for the company. Bank of America increased their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a report on Thursday, June 26th. Citigroup increased their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a report on Thursday, August 21st. Finally, Robert W. Baird upped their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Five investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Mettler-Toledo International presently has a consensus rating of "Moderate Buy" and an average price target of $1,311.11.

Insiders Place Their Bets

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the stock in a transaction on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the transaction, the chief financial officer directly owned 5,095 shares of the company's stock, valued at $6,389,588.55. This represents a 5.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of the firm's stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares in the company, valued at approximately $368,154.70. This represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,827 shares of company stock valued at $2,371,208 over the last three months. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD traded down $24.66 during mid-day trading on Friday, reaching $1,258.06. The company had a trading volume of 109,047 shares, compared to its average volume of 119,443. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,521.01. The stock has a market capitalization of $25.92 billion, a PE ratio of 31.86, a price-to-earnings-growth ratio of 3.85 and a beta of 1.37. The stock's 50 day moving average is $1,258.94 and its 200-day moving average is $1,185.32.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, topping the consensus estimate of $9.58 by $0.51. The firm had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business's quarterly revenue was up 3.9% on a year-over-year basis. During the same period in the prior year, the business posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.